NORMAL HUMAN VARIATION: REFOCUSSING THE ENHANCEMENT DEBATE.

This article draws attention to several common mistakes in thinking about biomedical enhancement, mistakes that are made even by some supporters of enhancement. We illustrate these mistakes by examining objections that John Harris has recently raised against the use of pharmacological interventions...

Descripción completa

Detalles Bibliográficos
Publicado en:Bioethics Vol. 29; no. 2; pp. 133 - 144
Autores principales: Kahane, Guy, Savulescu, Julian
Formato: Journal Article
Publicado: Wiley-Blackwell Feb2015
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=103789616&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 103789616
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        02699702
        6PJ
      jtl: Bioethics
      issn: 02699702
      maglogo: Y
    pubinfo:
      dt: Feb2015
      vid: 29
      iid: 2
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        103789616
        2012977997
        10.1111/bioe.12045
        NLM23906367
        103789616
      ppf: 133
      ppct: 11
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: NORMAL HUMAN VARIATION: REFOCUSSING THE ENHANCEMENT DEBATE.
      aug:
        au:
          Kahane, Guy
          Savulescu, Julian
        affil: Deputy Director, Uehiro Centre for Practical Ethics and the Oxford Centre for Neuroethics, Faculty of Philosophy, Oxford University
      sug:
        subj:
          Bioethics
          Serotonin
          Ergogenic Products
          Nootropic Agents
          Technology, Medical Ethical Issues
          Biomedical Engineering Ethical Issues
          Biological Products Ethical Issues
      ab: This article draws attention to several common mistakes in thinking about biomedical enhancement, mistakes that are made even by some supporters of enhancement. We illustrate these mistakes by examining objections that John Harris has recently raised against the use of pharmacological interventions to directly modulate moral decision-making. We then apply these lessons to other influential figures in the debate about enhancement. One upshot of our argument is that many considerations presented as powerful objections to enhancement are really strong considerations in favour of biomedical enhancement, just in a different direction. Another upshot is that it is unfortunate that much of the current debate focuses on interventions that will radically transform normal human capacities. Such interventions are unlikely to be available in the near future, and may not even be feasible. But our argument shows that the enhancement project can still have a radical impact on human life even if biomedical enhancement operated entirely within the normal human range.
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N